一项共同设计研究开发了早期的干预原型,以支持口服抗癌药物在乳腺癌中使用
Yejin Seo1, Karen Suchanek Hudmon1, Kellie Jones Weddle1
1College of Pharmacy, Purdue University, West Lafayette, IN, USA.
Patient preference and adherence
|February 25, 2026
概括
患者共同设计了用于治疗乳腺癌的口服抗癌药物 (OAM) 的干预措施. 原型包括一本手册和应用程序,以改善OAM遵守和患者支持.
科学领域:
- 在瘤学瘤学.
- 患者为中心的护理
- 医疗信息学 医疗信息学
背景情况:
- 乳腺癌是妇女死亡的主要原因.
- 口服抗癌药物 (OAMs) 增加了患者对管理的责任.
- 对OAM患者的患者支持不足是一个越来越令人担忧的问题.
研究的目的:
- 共同设计一个早期干预原型.
- 支持乳腺癌患者管理OAMs.
- 使用以患者为中心,参与式的设计方法.
主要方法:
- 在OAM上与五名乳腺癌患者进行参与式设计 (PD) 会议.
- PD涉及灵感,构想和融合阶段.
- 患者发现了挑战,并共同开发了解决方案.
主要成果:
- 主要挑战包括副作用管理和资源导航.
- 创建了10个解决方案,导致两个优先原型:手册和导航应用程序.
- 患者更喜欢手册的可用性和应用程序的沟通功能.
结论:
- 让患者作为共同设计者参与,对于干预开发是有价值的.
- 手册和应用程序原型都显示出改善OAM遵守的潜力.
- 这些发现为未来的口服抗癌药物支持干预提供了洞察力.
相关概念视频
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Dosage Regimens: Designs and Approaches
392
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
392
Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
Bioavailability Study Design: Healthy Subjects Versus Patients
190
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
190
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K


